Funder
Bankhead-Coley Foundation
Florida State University
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Makarev, E. et al. Common pathway signature in lung and liver fibrosis. Cell Cycle 15, 1667–1673,
https://doi.org/10.1080/15384101.2016.1152435
(2016).
2. Karsdal, M. A. et al. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 308, G807–830,
https://doi.org/10.1152/ajpgi.00447.2014
(2015).
3. Friedman, S. L. & Bansal, M. B. Reversal of hepatic fibrosis–fact or fantasy? Hepatology 43, S82–88 (2006).
4. Issa, R. et al. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J 17, 47–49,
https://doi.org/10.1096/fj.02-0494fje
(2003).
5. Leask, A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 106, 1675–1680, doi:106/11/1675 (2010).
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献